In addition to a role in craniofacial, neurulation and ectodermal defects, GRHL2 is thought to play a role in multiple types of cancer as a tumour suppressor or promoter and has predictive prognostic value in breast cancer and colorectal cancers (48). This evidence concerns the gene GRHL2 and breast cancer.